Zobrazeno 1 - 3
of 3
pro vyhledávání: '"F. Eltrudis"'
Autor:
Michela Barca, Francesco Atzori, Bruno Massidda, Luigi Minerba, M. Murgia, M. T. Ionta, A. Trogu, F. Eltrudis, A. Coinu, B. Frau
Publikováno v:
Journal of Clinical Oncology. 27:583-583
583 Background: Clinical data demonstrated that standard anthracycline-based chemotherapy may be less beneficial in TN. Conversely, there is extensive preclinical work showing that TN tumors are highly sensitive to platinum agents. Only a few studies
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::93ef502a21cc9d91535dd3c650abced4
https://doi.org/10.1200/jco.2009.27.15_suppl.583
https://doi.org/10.1200/jco.2009.27.15_suppl.583
Autor:
M. Barca, F. Eltrudis, Marina Elena Cazzaniga, A. Trogu, Sandro Barni, D. Guerzoni, F. Petrelli, Bruno Massidda, Luigi Minerba, M. T. Ionta
Publikováno v:
European Journal of Cancer Supplements. 5:206
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::d4d3c2436dd6eb11590c3e942735ca8e
https://doi.org/10.1016/s1359-6349(07)70837-6
https://doi.org/10.1016/s1359-6349(07)70837-6
Autor:
Maria Cristina Deidda, M. Murgia, M. T. Ionta, Bruno Massidda, A. Coinu, B. Frau, Luigi Minerba, Michela Barca, F. Eltrudis, Francesco Atzori
Publikováno v:
Journal of Clinical Oncology. 25:11024-11024
11024 Background: It is widely assumed that HER2-negative and hormone receptors negative tumors (Triple-Negative as TN) are associated with poor outcome and would benefit from intensified chemotherapy and/or from specific EGFR-targeted therapies.Neve
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1d3fba77eddf607c8578c82ea31b9bc7
https://doi.org/10.1200/jco.2007.25.18_suppl.11024
https://doi.org/10.1200/jco.2007.25.18_suppl.11024